PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Medical Affairs, Research and Development, Pear Therapeutics, Inc, Boston, MA, United States.\', \'Formerly with Xcenda, LLC., Palm Harbor, FL, United States.\', \'Strategic Therapeutics, LLC., Oro Valley, AZ, United States.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1080/00325481.2021.1884471
?:hasPublicationType
?:journal
  • Postgraduate medicine
is ?:pmid of
?:pmid
?:pmid
  • 33593201
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.587
?:rankingScore_hIndex
  • 46
is ?:relation_isRelatedTo_publication of
?:title
  • Evaluation of the cost-utility of a prescription digital therapeutic for the treatment of opioid use disorder.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all